Giulia Carola
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Giulia Carola has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Angel Raya
Stem Cell Potency Group, Regenerative Medicine Program, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Spain
3 shared publications - Antonella Consiglio
Department of Pathology and Experimental Therapeutics, Bellvitge University Hospital-IDIBELL, Barcelona, Spain
3 shared publications - Carles Calatayud
Department of Pathology and Experimental Therapeutics, Bellvitge University Hospital-IDIBELL, Barcelona, Spain
3 shared publications - Irene Fernandez-Carasa
Department of Pathology and Experimental Therapeutics, Bellvitge University Hospital-IDIBELL, Hospitalet de Llobregat, Spain
2 shared publications Ana Maria Cuervo
Albert Einstein College of Medicine, Bronx, NY 10461, USA
1 shared publication- Angelique di Domenico
Institute for Neurodegenerative Diseases, University of California, San Francisco, USA
1 shared publication
Latest Publications
- Open Access
- 2 May 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 6811
CRISPR/Cas9-mediated generation of a tyrosine hydroxylase reporter iPSC line for live imaging and isolation of dopaminergic neurons
Patient-specific induced pluripotent stem cells (iPSCs) are a powerful tool to investigate the molecular mechanisms underlying Parkinson’s disease (PD), and might provide novel platforms for systematic drug screening. Several strategies have been developed to generate iPSC-derived tyrosine hydroxylase (TH)-positive dopaminergic neurons (DAn), the clinically relevant cell type in PD; however, they often result in mixed neuronal cultures containing only a small proportion of TH-positive DAn. To overcome this limitation, we used CRISPR/Cas9-based editing to generate a human iPSC line expressing a fluorescent protein (mOrange) knocked-in at the last exon of the TH locus. After differentiation of the TH-mOrange reporter iPSC line, we confirmed that mOrange expression faithfully mimicked endogenous TH expression in iPSC-derived DAn. We also employed calcium imaging techniques to determine the intrinsic functional differences between dopaminergic and non-dopaminergic ventral midbrain neurons. Crucially, the brightness of mOrange allowed direct visualization of TH-expressing cells in heterogeneous cultures, and enabled us to isolate live mOrange-positive cells through fluorescence-activated cell sorting, for further differentiation. This technique, coupled to refined imaging and data processing tools, could advance the investigation of PD pathogenesis and might offer a platform to test potential new therapeutics for PD and other neurodegenerative diseases.
- 2 May 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 6811
Open AccessCRISPR/Cas9-mediated generation of a tyrosine hydroxylase reporter iPSC line for live imaging and isolation of dopaminergic neurons
Patient-specific induced pluripotent stem cells (iPSCs) are a powerful tool to investigate the molecular mechanisms underlying Parkinson’s disease (PD), and might provide novel platforms for systematic drug screening. Several strategies have been developed to generate iPSC-derived tyrosine hydroxylase (TH)-positive dopaminergic neurons (DAn), the clinically relevant cell type in PD; however, they often result in mixed neuronal cultures containing only a small proportion of TH-positive DAn. To overcome this limitation, we used CRISPR/Cas9-based editing to generate a human iPSC line expressing a fluorescent protein (mOrange) knocked-in at the last exon of the TH locus. After differentiation of the TH-mOrange reporter iPSC line, we confirmed that mOrange expression faithfully mimicked endogenous TH expression in iPSC-derived DAn. We also employed calcium imaging techniques to determine the intrinsic functional differences between dopaminergic and non-dopaminergic ventral midbrain neurons. Crucially, the brightness of mOrange allowed direct visualization of TH-expressing cells in heterogeneous cultures, and enabled us to isolate live mOrange-positive cells through fluorescence-activated cell sorting, for further differentiation. This technique, coupled to refined imaging and data processing tools, could advance the investigation of PD pathogenesis and might offer a platform to test potential new therapeutics for PD and other neurodegenerative diseases.
- Top Cited PapersOpen Access
- 1 February 2019
- Published by Elsevier in Stem Cell Reports
- Vol. 12 (2) , 213-229
Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson's Disease
- 1 February 2019
- Published by Elsevier in Stem Cell Reports
- Vol. 12 (2) , 213-229
Top Cited PapersOpen AccessPatient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson's Disease
- 1 October 2017
- Published by Elsevier in Current Opinion in Genetics & Development
- Vol. 46, 123-131
Modeling the genetic complexity of Parkinson's disease by targeted genome edition in iPS cells
- 1 October 2017
- Published by Elsevier in Current Opinion in Genetics & Development
- Vol. 46, 123-131
Modeling the genetic complexity of Parkinson's disease by targeted genome edition in iPS cells
- Open Access
- 7 October 2013
- Published by Wiley in Developmental Dynamics
- Vol. 243 (2) , 299-314
Analysis of three μ1‐AP1 subunits during zebrafish development
Background: The family of AP‐1 complexes mediates protein sorting in the late secretory pathway and it is essential for the development of mammals. The ubiquitously expressed AP‐1A complex consists of four adaptins γ1, β1, μ1A, and σ1A. AP‐1A mediates protein transport between the trans‐Golgi network and early endosomes. The polarized epithelia AP‐1B complex contains the μ1B‐adaptin. AP‐1B mediates specific transport of proteins from basolateral recycling endosomes to the basolateral plasma membrane of polarized epithelial cells. Results: Analysis of the zebrafish genome revealed the existence of three μ1‐adaptin genes, encoding μ1A, μ1B, and the novel isoform μ1C, which is not found in mammals. μ1C shows 80% sequence identity with μ1A and μ1B. The μ1C expression pattern largely overlaps with that of μ1A, while μ1B is expressed in epithelial cells. By knocking‐down the synthesis of μ1A, μ1B and μ1C with antisense morpholino techniques we demonstrate that each of these μ1 adaptins is essential for zebrafish development, with μ1A and μ1C being involved in central nervous system development and μ1B in kidney, gut and liver formation. Conclusions: Zebrafish is unique in expressing three AP‐1 complexes: AP‐1A, AP‐1B, and AP‐1C. Our results demonstrate that they are not redundant and that each of them has specific functions, which cannot be fulfilled by one of the other isoforms. Each of the μ1 adaptins appears to mediate specific molecular mechanisms essential for early developmental processes, which depends on specific intracellular vesicular protein sorting pathways. Developmental Dynamics 243:299–314, 2014.
- 7 October 2013
- Published by Wiley in Developmental Dynamics
- Vol. 243 (2) , 299-314
Open AccessAnalysis of three μ1‐AP1 subunits during zebrafish development
Background: The family of AP‐1 complexes mediates protein sorting in the late secretory pathway and it is essential for the development of mammals. The ubiquitously expressed AP‐1A complex consists of four adaptins γ1, β1, μ1A, and σ1A. AP‐1A mediates protein transport between the trans‐Golgi network and early endosomes. The polarized epithelia AP‐1B complex contains the μ1B‐adaptin. AP‐1B mediates specific transport of proteins from basolateral recycling endosomes to the basolateral plasma membrane of polarized epithelial cells. Results: Analysis of the zebrafish genome revealed the existence of three μ1‐adaptin genes, encoding μ1A, μ1B, and the novel isoform μ1C, which is not found in mammals. μ1C shows 80% sequence identity with μ1A and μ1B. The μ1C expression pattern largely overlaps with that of μ1A, while μ1B is expressed in epithelial cells. By knocking‐down the synthesis of μ1A, μ1B and μ1C with antisense morpholino techniques we demonstrate that each of these μ1 adaptins is essential for zebrafish development, with μ1A and μ1C being involved in central nervous system development and μ1B in kidney, gut and liver formation. Conclusions: Zebrafish is unique in expressing three AP‐1 complexes: AP‐1A, AP‐1B, and AP‐1C. Our results demonstrate that they are not redundant and that each of them has specific functions, which cannot be fulfilled by one of the other isoforms. Each of the μ1 adaptins appears to mediate specific molecular mechanisms essential for early developmental processes, which depends on specific intracellular vesicular protein sorting pathways. Developmental Dynamics 243:299–314, 2014.